글로벌 단백질 라벨링 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력 글로벌 단백질 라벨링 시장

Data Bridge Market Research에 따르면 단백질 라벨링 시장이 2022~2029년 예측 기간 동안 9.90%의 CAGR로 성장할 것으로 분석됩니다.

단백질 라벨링은 분자 라벨을 원하는 단백질 분자에 공유 결합시켜 라벨이 붙은 단백질과 그 결합체의 검출과 정제를 용이하게 하는 프로세스입니다. 이 기술은 바이오틴, 효소, 형광체, 방사성 동위 원소와 같은 다양한 단백질 분자를 원하는 단백질 표적에 공유 결합시키는 분자 라벨을 사용합니다.

증가하는 의료비 지출과 프로테오믹스 연구에 대한 관심이 향후 몇 년 동안 단백질 라벨링 시장을 주도할 것으로 예상됩니다. 또한 이 부문의 기술적 발전과 증가하는 연구 개발 지출이 향후 몇 년 동안 시장을 활성화할 것으로 예상됩니다. 또한 질량 분석 워크플로우와 바이오칩 소형화의 발전이 예측 기간 동안 시장을 주도할 것으로 예상됩니다.

의료비 지출 증가, 첨단 기술 확장에 대한 투자 수준 증가, 인구 고령화, 단백질 식별과 관련된 긍정적인 정부 정책으로 인해 2022~2029년 예측 기간 동안 단백질 라벨링 시장 성장이 가속화될 것으로 예상됩니다.

그러나 숙련된 전문가의 부족과 주요 업체 간의 경쟁은 예측 기간 동안 단백질 라벨링 시장 성장을 방해할 가능성이 높습니다.

This protein labelling market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on protein labelling market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Protein Labelling Market Scope and Market Size

Protein labelling market is segmented on the basis of labelling method, product, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on labelling method, the protein labelling market is segmented into in vitro Labelling, in vivo labelling and bioorthogonal Labelling. The in vitro Labelling segment is further sub-segmented on the basis of Labelling method into enzymatic Labelling, dye-based Labelling, cotranslational Labelling, site-specific Labelling, and nanoparticle Labelling. The in vivo Labelling segment is further sub-segmented on the basis of Labelling method into photoreactive Labelling and radioactive Labelling.
• Based on product, the global protein labelling market is segmented into reagents, kits and services segments. The reagents segment is further sub-segmented on the basis of product into enzymes, monoclonal antibodies, proteins, probes/tags, and other reagents.
• On the basis of application, the global protein labelling market is classified into immunological techniques, cell-based assays, fluorescence microscopy, protein microarrays, and mass spectrometry.
• Protein labelling market has also been segmented based on the end user into hospitals, academic institutes, research laboratories and diagnostic centers.

Protein Labelling Market Country Level Analysis

The protein labelling market is analysed and market size insights and trends are provided by country, labelling method, product, application and end user as referenced above.

The countries covered in the protein labelling market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the protein labelling market due to the presence of major players in the region working on improving their portfolios and offerings, as well as the rise in acceptance of protein labelling in tandem with the expansion of genomic sequencing and personalised medicine, which are the major factors driving the region's dominant position, whereas Asia-Pacific is expected to grow at the fastest rate during the forecast period of 2022 to 2029 due to higher healthcare spending.

The country section of the protein labelling market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The protein labelling market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for protein labelling market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the protein labelling market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Protein Labelling Market Share Analysis

The protein labelling market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to protein labelling market.

단백질 라벨링 시장의 주요 기업으로는 Thermo Fisher Scientific, Inc., Merck KGaA, Perkinelmer, Inc., F. Hoffman-La Roche AG, General Electric Company, Kaneka Corporation, Li-Cor, Inc., Promega Corporation, New England Biolabs, Seracare Life Sciences, Inc., Luminex Corporation, Active Motif, Inc., Takara Bio USA, Inc., Candor Bioscience GMBH, Innova Biosciences Ltd., Biotium, Inc., Qiagen NV, Agilent Technologies, Inc., Caprion Biosciences, Nanotemper Technologies GMBH, Bio-Rad Laboratories, Bruker Inc., Kirkegaard & Perry Laboratories, Eurogentec SA, B. Braun Melsungen AG, Ethicon, Inc. 등이 있습니다.

SKU-18812